Literature DB >> 11300420

Task force 3: workforce description and educational requirements for the care of adults with congenital heart disease.

J S Child, R L Collins-Nakai, J S Alpert, J E Deanfield, L Harris, P McLaughlin, P D Miner, G D Webb, R G Williams.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11300420     DOI: 10.1016/s0735-1097(01)01276-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  [Recommendations on the structure of the care of adults with congenital heart disease (GUCH patients) in Austria -- update 2011th].

Authors:  Harald M Gabriel; Helmut Baumgartner; Andreas Gamillscheg; Igor Knez; Robert Maier; Ina Michel-Behnke; Bert Nagel; Raphael Rosenhek; Jörg Ingolf Stein; Gregor Wollenek; Johannes Mair
Journal:  Wien Klin Wochenschr       Date:  2013-12-17       Impact factor: 1.704

2.  Transition and transfer from pediatric to adult care of young adults with complex congenital heart disease.

Authors:  Alison Knauth Meadows; Valerie Bosco; Elizabeth Tong; Susan Fernandes; Arwa Saidi
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

3.  Adults with chronic health conditions originating in childhood: inpatient experience in children's hospitals.

Authors:  Denise M Goodman; Matthew Hall; Amanda Levin; R Scott Watson; Roberta G Williams; Samir S Shah; Anthony D Slonim
Journal:  Pediatrics       Date:  2011-06-27       Impact factor: 7.124

4.  Adult congenital heart disease: intensive care management and outcome prediction.

Authors:  Susanna Price; Sian Isobel Jaggar; Simon Jordan; Sarah Trenfield; Mohammed Khan; Babulal Sethia; Darryl Shore; Timothy W Evans
Journal:  Intensive Care Med       Date:  2007-02-27       Impact factor: 17.440

5.  Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK.

Authors: 
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.